RxDoctor Payments Data

Chirag Patel, MD

Internal Medicine · Sioux Falls, SDNPI 1710141809

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $724 of the $924 with a category attached, or 78.3%. It is spread thinly across 12 manufacturers, the largest accounting for just 21.7% — the pattern of someone who eats at a lot of different presentations.

$924in general payments, 2019–2025

Across 37 payments — averaging $24.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$200
  • GSK$127
  • Boehringer Ingelheim$126
  • EMD Serono, Inc.$121
  • AstraZeneca$114
  • Sanofi$90
  • plus $148 from 6 others

What the payments were for

  • Travel & lodging$20022%
  • Food & beverage$72478%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$924 in reported general payments places this provider in the 85th percentile of 178 internal medicine providers in South Dakota.

See all internal medicine providers in South Dakota

Medicare billing

Part B allowed, 2024
$142,191
Medicare patients
371
Services billed
910

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent SyringeDupilumab20$82,933
Trelegy ElliptaFluticasone/Umeclidin/Vilanter70$53,501
XolairOmalizumab24$48,248
Spiriva HandihalerTiotropium Bromide12$12,829
Advair HfaFluticasone Propion/Salmeterol22$11,808
Breo ElliptaFluticasone/Vilanterol20$9,531
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr17$8,964
Incruse ElliptaUmeclidinium Bromide20$7,388
DuleraMometasone/Formoterol14$6,933
Albuterol Sulfate HfaAlbuterol Sulfate130$3,775
SymbicortBudesonide/Formoterol Fumarate12$3,740
Methylphenidate Hcl11$321
Montelukast Sodium23$207
Prednisone29$71
Azithromycin15$58

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta$127$79,383127 claims
MerckDulera$11$6,93314 claims
AstraZenecaSymbicort$114$3,74012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 178 internal medicine providers in South Dakota.

Other internal medicine in Sioux Falls

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →